TransMedics Group, Inc. Net Income (Loss) Available to Common Stockholders, Diluted
TransMedics Group, Inc. (TMDX) reported Net Income (Loss) Available to Common Stockholders, Diluted of $16.52 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2026-08-04
- TransMedics Group, Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2026-06-30 was $16.52M, a 55.67% decline year-over-year.
- TransMedics Group, Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2026-03-31 was $7.32M, a 73.90% decline year-over-year.
- TransMedics Group, Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2025-12-31 was $105.43M, a 1437.61% increase year-over-year.
- TransMedics Group, Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2025-09-30 was $26.90M, a 538.02% increase year-over-year.
- TransMedics Group, Inc. net income (loss) available to common stockholders, diluted for fiscal 2025 was $197.58M, a 457.12% increase from fiscal 2024.
- TransMedics Group, Inc. net income (loss) available to common stockholders, diluted for fiscal 2024 was $35.46M.
- TransMedics Group, Inc. net income (loss) available to common stockholders, diluted for fiscal 2023 was -$25.03M.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 9 month | Net Income (Loss) Available to Common Stockholders, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | $16.52M 10-Q · filed 2026-08-04 | $22.00M 10-Q · filed 2026-08-04 | $129.27M derived: sum of 3 quarters · filed 2026-08-04 | $156.16M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $7.32M 10-Q · filed 2026-05-05 | $112.75M derived: sum of 2 quarters · filed 2026-05-05 | $139.65M derived: sum of 3 quarters · filed 2026-05-05 | $176.91M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $105.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $132.33M derived: sum of 2 quarters · filed 2026-02-24 | $169.59M derived: sum of 3 quarters · filed 2026-08-04 | $197.58M 10-K · filed 2026-02-24 |
| 2025-09-30 | $26.90M 10-Q · filed 2025-10-29 | $64.16M derived: sum of 2 quarters · filed 2026-08-04 | $92.14M 10-Q · filed 2025-10-29 | $99.04M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $37.26M 10-Q · filed 2026-08-04 | $65.29M 10-Q · filed 2026-08-04 | $72.14M derived: sum of 3 quarters · filed 2026-08-04 | $76.36M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $28.03M 10-Q · filed 2026-05-05 | $34.88M derived: sum of 2 quarters · filed 2026-05-05 | $39.10M derived: sum of 3 quarters · filed 2026-05-05 | $51.29M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $6.86M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $11.07M derived: sum of 2 quarters · filed 2026-02-24 | $23.27M derived: sum of 3 quarters · filed 2026-02-24 | $35.46M 10-K · filed 2026-02-24 |
| 2024-09-30 | $4.22M 10-Q · filed 2025-10-29 | $16.41M derived: sum of 2 quarters · filed 2025-10-29 | $28.61M 10-Q · filed 2025-10-29 | |
| 2024-06-30 | $12.19M 10-Q · filed 2025-07-30 | $24.39M 10-Q · filed 2025-07-30 | ||
| 2024-03-31 | $12.20M 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | -$25.03M 10-K · filed 2026-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |